Masafumi Watanabe

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

K. Kario, N. Kitamura, Y. Nakajima, 2020, Diabetes Therapy.

Left ventricular lead implantation using the crossover technique in a steeply bifurcated lateral branch

T. Arimoto, Naoaki Hashimoto, T. Shikama, 2023, HeartRhythm case reports.